Reckitt Benckiser Plc Fined $16.4 Million by U.K. Regulator Over Hearturn Drug Supplies to the National Health Service

October 15, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Bloomberg -- Reckitt Benckiser Group Plc was fined 10.2 million pounds ($16.4 million) by a U.K. regulator for wrongfully stopping supplies of a heartburn medicine to the National Health Service after its patent expired.

Twitter
LinkedIn
Facebook
Email
Print

Legal Regulatory Europe